International Patent: 4-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)QUINOLINE DERIVATIVES AND SIMILAR COMPOUNDS AS 5-HT2AR ACTIVATORS FOR THE TREATMENT OF NEUROLOGICAL DISEASES

GENEVA, July 31 -- BRANDARIS THERAPEUTICS B.V. filed a patent application (EP2026/051922) for “4-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)QUINOLINE DERIVATIVES AND SIMILAR COMPOUNDS AS 5-HT2AR ACTIVATORS FOR THE TREATMENT OF NEUROLOGICAL DISEASES”. With publication no. WO/2026/159333, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 401/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....